Brodalumab: Six-Year US Pharmacovigilance Report

By sjmartinez • November 27, 2024

Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Yoon SH, Rawnsley NN, Goehring EL Jr, Mangin GD, Jacobson AA. Brodalumab: Six-Year US Pharmacovigilance Report. Dermatol Ther (Heidelb). 2024 Nov 26. doi: 10.1007/s13555-024-01304-y. Epub ahead of print. PMID: 39589679.

Tags: Adverse events, Dermatology, Drug reaction, psoriasis, Publications, real-world, safety

Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy

Burshtein J, Bunick CG, Vleugels RA, Armstrong AW, Golant AK, Schlesinger T, Strober BE, Song EJ, Gold LS, Lebwohl M. Systemic Corticosteroid Use in Atopic[...]

Evidence of neuronal DNA damage in the brains of patients with Rett syndrome

Morales A, Korsakova E, Mansooralavi N, Soliman P, Jahanbani S, Olsen ML, Badhuri A, Lowry WE. Evidence of neuronal DNA damage in the brains of[...]

Multi-omics signature of healthy versus unhealthy lifestyles reveals associations with diseases

Fu G, Rushing BR, Graves L, Nieman DC, Pellegrini M, Soldano M, Thompson MJ, Sakaguchi CA, Pathmasiri W, Sumner SJ. Multi-omics signature of healthy versus[...]